PICS: WHAT IT HAS MEANT TO MALAYSIA - PowerPoint PPT Presentation

1 / 16
About This Presentation
Title:

PICS: WHAT IT HAS MEANT TO MALAYSIA

Description:

Malaysia became the 26th member of the Pharmaceutical ... Malaysia is a a ... Malaysia's ascension into PIC/S has opened new doors for the domestic ... – PowerPoint PPT presentation

Number of Views:281
Avg rating:3.0/5.0
Slides: 17
Provided by: matthieub
Category:
Tags: has | malaysia | meant | pics | what | malaysia

less

Transcript and Presenter's Notes

Title: PICS: WHAT IT HAS MEANT TO MALAYSIA


1
PIC/S WHAT IT HAS MEANT TO MALAYSIA
  • ABIDA HAQ
  • NATIONAL PHARMACEUTICAL CONTROL BUREAU
  • MINISTRY OF HEALTH MALAYSIA

2
BACKGROUND
  • Malaysia became the 26th member of the
    Pharmaceutical Inspection Cooperation Scheme
    (PIC/S) in January 2002.
  • The only other country in the Asian region which
    is also a PIC/S member is Singapore
  • Thailand was inspected in January 2008 by four
    PIC/s auditors as part of their application for
    membership
  • Indonesia and Philippines have expressed their
    interest in joining PIC/S
  • Taiwan had previously applied but due to some
    technicalities, have not proceeded with their
    application
  • Currently there are 33 participating authorities
    in PIC/S

3
PIC/S' MISSION
  • "to lead the international development,
    implementation and maintenance of harmonised Good
    Manufacturing Practice (GMP) standards and
    quality systems of inspectorates in the field of
    medicinal products."

4
CURRENT SCENARIO
  • Malaysia is a a developing nation
  • Realises the need for a certain degree of self-
    dependency and self- sufficiency in the supply of
    medicines
  • Lead to the growth of the domestic pharmaceutical
    industry

5
GOVERNMENT SUPPORT
  • In recognition of the strategic importance of the
    pharmaceutical industry, a blueprint for the
    industry has been prepared by the Malaysia
    Industry-Government Group of High Technology
    (MIGHT).

6
STANDARDS
  • GMP
  • To ensure that medicines produced domestically
    comply with the same standards in terms of
    quality, efficacy and safety as imported
    products
  • GMP standards used evolved from Malaysian
    standards based on WHO to the European standards

7
IMPACT ON THE INDUSTRY
  • As compliance with high GMP standards comes at a
    very costly price, it has not been viable for
    Malaysian manufacturers to rely only on the
    Malaysian market for their products

8
TRADE ISSUES
  • In general, penetrating foreign markets is not
    easy without international confidence in the
  • standards adopted by the drug regulatory
    authority,
  • quality of the medicines produced,
  • level of GMP implemented by the manufacturers.
  • Malaysias ascension into PIC/S has opened new
    doors for the domestic pharmaceutical industry.

9
BENEFITS
  • GMP inspectors benefited from increased training
    opportunities by attending
  • PIC/S Seminars
  • Expert Circles
  • PIC/S Joint Visits Programme.
  • PIC/S guidance documents have served to
    standardise and harmonise the understanding and
    interpretation of GMP

10
BENEFITS
  • Malaysia is currently studying the PIC/S guides
    in its efforts to qualify blood collection
    facilities and those involved in tissues and cell
    cultures.

11
BENEFITS
  • Networking and the feeling of camaraderie among
    members is demonstrated through the willingness
    to share knowledge and to undertake training of
    fellow inspectors especially in specialised
    areas.

12
MUTUAL RECOGNITION AGREEMENTS
  • Membership in PIC/S may also facilitate the
    conclusion of agreements between Members at
    various levels.
  • At the ASEAN level, the Pharmaceutical Products
    Working Group has agreed to use the PIC/S code of
    GMP or its equivalent as the basis for entering
    into the proposed Mutual Recognition Agreement
    for GMP amongst the ASEAN countries.

13
ASEAN MRA for GMP
  • Final draft of the MRA was discussed at the 14
    Pharmaceutical Products Working Group Meeting in
    Vientiane, Lao in February 2008
  • Its implementation will probably follow the
    ASEAN-x principle whereby countries which are
    ready will enter into the MRA first without
    waiting for general acceptance by all 10 ASEAN
    countries

14
ASEAN MRA for GMP
  • When this MRA becomes a reality, it will
    translate into benefits for the regulators and
    the industry both financially and non-financially
    through mutual acceptance of audit reports,
    reduced duplication of inspections and broader
    market access

15
ULTIMATE BENEFIT
  • To the patient and the consumer, it means
    medicines which are safe, efficacious and of
    reliable quality which will result in improved
    healthcare

16
THANK YOUTERIMA KASIH
Write a Comment
User Comments (0)
About PowerShow.com